Article Text

Download PDFPDF
Pharmacogenomics: marshalling the human genome to individualise drug therapy
  1. W E Evans
  1. Correspondence to:
    Dr W E Evans, St Jude Children’s Research Hospital, 332 N Lauderdale, Memphis, TN 38101–0318, USA;


Pharmacogenomics aims to identify the inherited basis for interindividual differences in drug response, and translate this to molecular diagnostics that can be used to individualise drug therapy. This review uses a number of published examples of inherited differences in drug metabolising enzymes, drug transporters, and drug targets (for example, receptors) to illustrate the potential importance of inheritance in determining the efficacy and toxicity of medications in humans. It seems that this field is at the early stages of developing a powerful set of molecular diagnostics that will have profound utility in optimising drug therapy for individual patients.

  • pharmocogenomics

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.